Differences in Chlamydia trachomatis serovar E growth rate in polarized endometrial and endocervical epithelial cells grown in three-dimensional culture

Infection and Immunity

Volumn 75, Issue 2, 2007, Pages 553-564

  Guseva, Natalia V ^a   Dessus Babus, Sophie ^a   Moore, Cheryl G ^a   Whittimore, Judy D ^a   Wyrick, Priscilla B ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN;

ANIMAL CELL; ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CELL STRUCTURE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; ENDOMETRIUM CELL; FIBROBLAST; GENE REPLICATION; GENETIC TRANSCRIPTION; GROWTH RATE; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; UTERINE ENDOCERVIX;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE; CELL POLARITY; CHLAMYDIA TRACHOMATIS; CYTOPLASM; DNA REPLICATION; DNA, BACTERIAL; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; HELA CELLS; HUMANS; INCLUSION BODIES; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MICROSPHERES; RNA, BACTERIAL; TRANSCRIPTION, GENETIC;

EID: 33846829488     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01517-06     Document Type: Article

References (56)

1. Abdelrahman, Y. M., and R. J. Belland. 2005. The chlamydial developmental cycle. FEMS Microbiol. Rev. 29:949-959.
2. Arici, A., E. Seli, L. M. Senturk, L. S. Gutierrez, E. Oral, and H. S. Taylor. 1998. Interleukin-8 in the human endometrium. J. Clin. Endocrinol. Metab. 83:1783-1787.
3. Belland, R. J., G. Zhong, D. D. Crane, D. Hogan, D. Sturdevant, J. Sharma, W. L. Beatty, and H. D. Caldwell. 2003. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc. Natl. Acad. Sci. USA 100:8478-8483.
4. Boeckman, F., L. Tan, M. Brisson, R. Park, and K. Hamby. 2001. Real-time multiplex PCR from genomic DNA using the iCycler iQ detection system. Bulletin 2679. Bio-Rad Laboratories, Richmond, CA.
5. Carabeo, R. A., S. S. Grieshaber, E. Fischer, and T. Hackstadt. 2002. Chlamydia trachomatis induces remodeling of the actin cytoskeleton during attachment and entry into HeLa cells. Infect. Immun. 70:3793-3803.
6. Carvalho, H. M., L. D. Teel, G. Goping, and A. D. O'Brien. 2005. A three-dimensional tissue culture model for the study of attach and efface lesion formation by enteropathogenic and enterohaemorrhagic Escherichia coli. Cell Microbiol. 7:1771-1781.
7. Centers for Disease Control and Prevention. 2003. Sexually transmitted disease surveillance 2002 supplement: Chlamydial Prevalence Monitoring Project annual report 2002. [Online.] http://www.cdc.gov/std/ chlamydia2002/chlamydia2002.pdf.
8. Centers for Disease Control and Prevention. 2005. sexually transmitted disease surveillance 2004 supplement: Chlamydia Prevalence Monitoring Project annual report 2004, p. 24. [Online.] http://www.cdc.gov/std/ Chlamydia2004/ctsupplement_2004FINAL.pdf.
9. Clausen, J. D., G. Christiansen, H. U. Holst, and S. Birkelund. 1997. Chlamydia trachomatis utilizes the host cell microtubule network during early events of infection. Mol. Microbiol. 25:441-449.
10. Clifton, D. R., K. A. Fields, S. S. Grieshaber, C. A. Dooley, E. R. Fischer, D. J. Mead, R. A. Carabeo, and T. Hackstadt. 2004. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc. Natl. Acad. Sci. USA 101:10166-10171.
11. Cossart, P., and M. Lecuit. 1998. Interactions of Listeria monocytogenes with mammalian cells during entry and actin-based movement: bacterial factors, cellular ligands and signaling. EMBO J. 17:3797-3806.
12. Darville, T. L. 2000. Chlamydia spp., p. 229-261. In J. P. Nataro (ed.), Persistent bacterial infections. ASM Press, Washington, DC.
13. Dautry-Varsat, A., A. Subtil, and T. Hackstadt. 2005. Recent insights into the mechanisms of Chlamydia entry. Cell. Microbiol. 7:1714-1722.
14. Dean, D., R. J. Suchland, and W. E. Stamm. 2000. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J. Infect. Dis. 182:909-916.
15. Deka, S., J. Vanover, J. Sun, J. Kintner, J. Whittimore, and R. Schoborg. An early event in herpes simplex virus type-2 replication cycle is sufficient to induce Chlamydia trachomatis persistence. Cell. Microbiol., in press.
16. Dessus-Babus, S., S. T. Knight, and P. B. Wyrick. 2000. Chlamydial infection of polarized HeLa cells induces PMN chemotaxis but the cytokine profile varies between disseminating and non-disseminating strains. Cell. Microbiol. 2:317-327.
17. Dessus-Babus, S. C., T. L. Darville, F. P. Cuozzo, K. Ferguson, and P. B. Wyrick. 2002. Differences in innate immune responses (in vitro) to HeLa cells infected with non-disseminating serovar E and disseminating serovar L2 of Chlamydia trachomatis. Infect. Immun. 70:3234-3248.
18. Discher, D. E., P. Janmey, and Y. L. Wang. 2005. Tissue cells feel and respond to the stiffness of their substrate. Science 310:1139-1143.
19. Gabel, B. R., C. Elwell, S. C. van Ijzendoorn, and J. N. Engel. 2004. Lipid raft-mediated entry is not required for Chlamydia trachomatis infection of cultured epithelial cells. Infect. Immun. 72:7367-7373.
20. Guseva, N. V., S. T. Knight, J. D. Whittimore, and P. B. Wyrick. 2003. Primary cultures of female swine genital epithelial cells in vitro: a new approach for the study of hormonal modulation of Chlamydia infection. Infect. Immun. 71:4700-4710.
21. Guseva, N. V., S. C. Dessus-Babus, J. D. Whittimore, C. G. Moore, and P. B. Wyrick. 2005. Characterization of estrogen-responsive epithelial cell lines and their infectivity by genital Chlamydia trachomatis. Microbes Infect. 7:1469-1481.
22. Hopper, S., J. S. Wilbur, B. L. Vasquez, J. Larson, S. Clary, I. J. Mehr, H. S. Seifert, and M. So. 2000. Isolation of Neisseria gonorrhoeae mutants that show enhanced trafficking across polarized T84 epithelial monolayers. Infect. Immun. 68:896-905.
23. Igietseme, J. U., P. B. Wyrick, D. Goyeau, and R. G. Rank. 1994. An in vitro model for immune control of chlamydial growth in polarized epithelial cells. Infect. Immun. 62:3528-3535.
24. Jutras, I., L. Abrami, and A. Dautry-Varsat. 2003. Entry of the Lymphogranuloma venereum strain of Chlamydia trachomatis into host cells involves cholesterol-rich membrane domains. Infect. Immun. 71:260-266.
25. Kane, C. D., and G. I. Byrne. 1998. Differential effects of gamma interferon on Chlamydia trachomatis growth in polarized and nonpolarized human epithelial cells in culture. Infect. Immun. 66:2349-2351.
26. Kane, C. D., R. M. Vena, S. P. Ouellette, and G. I. Byrne. 1999. Intracellular tryptophan pool sizes may account for differences in gamma interferon-mediated inhibition and persistence of chlamydial growth in polarized and nonpolarized cells. Infect. Immun. 67:1666-1671.
27. Kazmierczak, B. I., K. Mostov, and J. N. Engel. 2001. Interaction of bacterial pathogens with polarized epithelium. Annu. Rev. Microbiol. 55:407-435.
28. Kenny, B., R. DeVinney, M. Stein, D. J. Reinscheid, E. A. Frey, and B. B. Finlay. 1997. Enteropathogenic Escherichia coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-520.
29. Linzmeier, R. M., and T. Ganz. 2005. Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha-and beta-defensin regions at 8p22-p23. Genomics 86:423-430.
30. Merz, A. J., D. B. Rifenbery, C. G. Arvidson, and M. So. 1996. Traversal of a polarized epithelium by pathogenic neisseriae: facilitation by type IV pili and maintenance of epithelial barrier function. Mol. Med. 2:745-754.
31. Michelini, M., A. Rosellini, V. Mandys, T. Simoncini, and R. P. Revoltella. 2005. Cytoarchitecture modifications of the human uterine endocervical mucosa in long-term three-dimensional organotypic culture. Pathol. Res. Pract. 201:679-689.
32. Miyairi, I., O. S. Mahdi, S. P. Ouellette, R. J. Belland, and G. I. Byrne. 2006. Different growth rates of Chlamydia trachomatis biovars reflect pathotype. J. Infect. Dis. 194:350-357.
33. Moorman, D. R., J. W. Sixbey, and P. B. Wyrick. 1986. Interaction of Chlamydia trachomatis with human epithelium in culture. J. Gen. Microbiol. 132:1055-1067.
34. Nickerson, C. A., and C. M. Ott. 2004. A new dimension in modeling infectious disease. ASM News 70:171-175.
35. Norkin, L. C., S. A. Wolfrom, and E. S. Stuart. 2001. Association of caveolin with Chlamydia trachomatis inclusions at early and late stages of infection. Exp. Cell Res. 266:229-238.
36. O'Brien, L. E., M. M. Zegers, and K. E. Mostov. 2002. Building epithelial architecture: insights from three-dimensional culture models. Nat. Rev. Mol. Cell. Biol. 3:531-537.
37. Paul, T. R., S. T. Knight, J. E. Raulston, and P. B. Wyrick. 1997. Delivery of azithromycin to Chlamydia trachomatis-infected polarized human endometrial cells by polymorphonuclear leucocytes. J. Antimicrob. Chemother. 39:623-630.
38. Pharmacia Fine Chemicals. 1981. Microcarrier cell culture: principles and methods. Almqvist and Wiksell Tryckeri AB, Uppsala, Sweden.
39. Raulston, J. E. 1994. Pharmacokinetics of azithromycin and erythromycin in human endometrial epithelial cells and in cells infected with Chlamydia trachomatis. J. Antimicrob. Chemother. 34:765-776.
40. Sansonetti, P. J. 2001. Rupture, invasion, and inflammatory destruction of the intestinal barrier by Shigella, making sense of prokaryote-eukaryote cross-talks. FEMS Microbiol. Rev. 25:3-14.
41. Schachter, J. 1990. Infection and disease epidemiology, p. 139-169. In R. S. Stephens (ed.), Chlamydia: intracellular biology, pathogenesis, and immunity. ASM Press, Washington, DC.
42. Schachter, J., and P. B. Wyrick. 1994. Culture and isolation of Chlamydia trachomatis, p. 377-390. In V. L. Clark and P. M. Bavoil (ed.), Methods in enzymology: bacterial pathogenesis, vol. 236, part B. Interaction of pathogenic bacteria with host cells. Academic Press, Inc., San Diego, CA.
43. Shannon, J. E. 1981. Chlamydiae need the real McCoy. ATCC Quarterly Newsl. 1:2-3.
44. Shaw, E. I., C. A. Dooley, E. R. Fischer, M. A. Scidmore, K. A. Fields, and T. Hackstadt. 2000. Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle. Mol. Microbiol. 37:913-925.
45. Stevens, M. M., and J. H. George. 2005. Exploring and engineering the cell surface interface. Science 310:1135-1138.
46. Stuart, E. S., W. C. Webley, and L. C. Norkin. 2003. Lipid rafts, caveolae, caveolin-1, and entry by chlamydiae into host cells. Exp. Cell Res. 287:67-78.
47. Tam, J. E., S. T. Knight, C. H. Davis, and P. B. Wyrick. 1992. Eukaryotic cells grown on microcarrier beads offer a cost-efficient way to propagate Chlamydia trachomatis. BioTechniques 13:374-378.
48. Unsworth, B. R., and P. I. Lelkes. 1998. Growing tissues in microgravity. Nat. Med. 4:901-907.
49. Webley, W. C., L. C. Norkin, and E. S. Stuart. 2004. Caveolin-2 associates with intracellular chlamydial inclusions independently of caveolin-1. BMC Infect. Dis. 4:23.
50. Wyrick, P. B., J. Choong., C. H. Davis, S. T. Knight, M. O. Royal, A. S. Maslow, and C. R. Bagnell. 1989. Entry of genital Chlamydia trachomatis into polarized human epithelial cells. Infect. Immun. 57:2378-2389.
51. Wyrick, P. B., C. H. Davis, J. E. Raulston, S. T. Knight, and J. Choong. 1994. Effect of clinically relevant culture conditions on antimicrobial susceptibility of Chlamydia trachomatis. Clin. Infect. Dis. 19:931-936.
52. Wyrick, P. B., D. G. Gerbig, S. T. Knight, and J. E. Raulston. 1996. Accelerated development of genital Chlamydia trachomatis serovar E in McCoy cells grown on microcarrier beads. Microb. Pathog. 20:31-40.
53. Wyrick, P. B., S. T. Knight, T. R. Paul, R. G. Rank, and C. S. Barbier. 1999. Persistent chlamydial antigens in antibiotic-exposed infected cells trigger neutrophil chemotaxis. J. Infect. Dis. 179:954-966.
54. Wyrick, P. B. 2000. Intracellular survival by Chlamydia. Cell Microbiol. 2:275-282.
55. Yeaman, C., K. K. Grindstaff, and W. J. Nelson. 1999. New perspectives on mechanisms involved in generating epithelial cell polarity. Physiol. Rev. 79:73-98.
56. Zhang, L., A. L. Douglas, and T. P. Hatch. 1998. Characterization of a Chlamydia psittaci DNA binding protein (EUO) synthesized during the early and middle phases of the developmental cycle. Infect. Immun. 66:1167-1173.